86.21.Z - General medical practice
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
72.19.Z - Scientific research and development activities
86.22.Z - Specialist medical practice
86.23.Z - Dental practice
86.90.A - Healthcare
86.90.D - Healthcare
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0 | 0 | 0 | -0,3 |
EBITDA | 0 | 0 | 0,2 | 334,6 |
Short time liabilities | 0,5 | 0,4 | 0,4 | 6,4 |
Equity capital | 0,3 | 0,3 | 0,4 | 8,9 |
Operating profit (EBIT) | 0 | 0 | 0 | -0,6 |
Assets | 0,8 | 0,7 | 0,8 | 12 |
Net profit (loss) | 0 | 0 | 0 | -0,3 |
Cash | 0,1 | 0,2 | 0,2 | -12,9 |
Net income from sale | 6,5 | 5,9 | 6,5 | 10 |
Liabilities and provisions for liabilities | 0,5 | 0,4 | 0,5 | 14,3 |
Working assets | 0,7 | 0,7 | 0,8 | 8,5 |
Depreciation | 0 | 0 | 0,1 | 2507,9 |
% | % | % | p.p. | |
Profitability of capital | 6,7 | 9 | 8,2 | -0,8 |
Equity capital to total assets | 38,8 | 43,9 | 42,7 | -1,2 |
Gross profit margin | 0,3 | 0,5 | 0,5 | 0 |
EBITDA Margin | 0,4 | 0,6 | 2,5 | 1,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 26 | 26 | 25 | -1 |
Current financial liquidity indicator | 1.568981409072876 | 1.7213462591171265 | 1.6329330205917358 | -0,1 |
Net dept to EBITDA | -3.1098248958587646 | -5.17325496673584 | -1.0371371507644653 | 4,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane